EX-FILING FEES 4 tm238686d1_exfilingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-8

(Form Type)

 

Tabula Rasa HealthCare, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 
  Newly Registered Securities
 

 

 

 

Security

Type

Security
Class 
Title(1)

 

 

Fee

Calculation
or Carry
Forward

Rule

 

Amount

Registered
(1)

 

Proposed

Maximum

Offering
Price

Per Unit
(2)

 

Proposed

Maximum

Aggregate

Offering Price
(2)

    Fee Rate

Amount of

Registration
Fee

Carry
Forward
Form 
Type
Carry
Forward
File
Number
Carry
Forward
Initial
Effective
Date
Filing Fee
Previously
Paid in
Connection
with Unsold
Securities to be
Carried
Forward
Fees to be Paid Equity Common Stock, par value $0.0001 per share Rule 457(c) and Rule 457 (h)    1,356,454   $6.21   $8,423,579.34     $110.20 per $1,000,000.00 $928.28 - - - -
Fees Previously Paid - - -   -   -   -     - - - - - -
  Carry Forward Securities
Carry Forward Securities -   -   -     - - - - - -
 

Total Offering Amounts

      $8,423,579.34       $928.28        
  Total Fees Previously Paid               -        
  Total Fee Offsets               -        
  Net Fee Due               $928.28        

 

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 shall also cover any additional shares of the registrant’s common stock, par value $0.0001 per share (the “Common Stock”) which become issuable under the Tabula Rasa HealthCare, Inc. 2016 Omnibus Incentive Compensation Plan by reason of any stock dividend, stock split, recapitalization, or any other similar transaction effected without the receipt of consideration which results in an increase in the number of outstanding shares of Common Stock.
(2) Estimated solely for the purpose of determining the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, based on the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on March 3, 2023.